DGAP-News: Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK
DGAP-News: Moderna, Inc.
/ Key word(s): Miscellaneous
Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK
15.08.2022 / 13:30
The issuer is solely responsible for the content of this announcement.